ClinicalTrials.govpublic full text
BAL/BOT/agenT-797 in pMMR CRC With Liver Metastases
colorectal cancer metastatic, metastatic colorectal cancer, pmmr colorectal cancer, liver metastases, immunotherapy, checkpoint inhibitor, anti-pd-1, anti-ctla-4, inkt cell therapy, balstilimab, botensilimab, agent-797
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 900062
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.